Phenome-wide Mendelian randomization analysis reveals multiple health comorbidities of coeliac disease.

Authors:
Yuan S; Jiang F; Chen J; Lebwohl B; Green PHR and 4 more

Journal:
EBioMedicine

Publication Year: 2024

DOI:
10.1016/j.ebiom.2024.105033

PMCID:
PMC10900254

PMID:
38382313

Journal Information

Full Title: EBioMedicine

Abbreviation: EBioMedicine

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of interests Dr. Leffler is an employee of Takeda. Dr. Ludvigsson has coordinated an unrelated study for the Swedish IBD quality register (SWIBREG). That study received funding from Janssen Corporation. Dr. Ludvigsson has also received financial support from MSD, developing a paper reviewing national healthcare registers in China. Dr. Ludvigsson has an ongoing research collaboration with Takeda. The other authors report no conflicts of interest."

Evidence found in paper:

"This research was conducted using the UK Biobank study under Application Number 66354. We want to acknowledge the participants and investigators of the FinnGen study. This project was funded by 10.13039/501100004047Karolinska Institutet and the 10.13039/501100004359Swedish Research Council. Dr. Leffler is an employee of Takeda. Dr. Ludvigsson has coordinated an unrelated study for the Swedish IBD quality register (SWIBREG). That study received funding from Janssen Corporation. Dr. Ludvigsson has also received financial support from MSD, developing a paper reviewing national healthcare registers in China. Dr. Ludvigsson has an ongoing research collaboration with Takeda. The other authors report no conflicts of interest."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025